4 Patents
- US118575742024Genetically Engineered T Cells with Regnase-1 And/or TGFBRII Disruption Have Improved Functionality and Persistence
CRISPR Therapeutics AG
0 cites - US117952382023Anti-idiotype Antibodies Targeting Anti-cd70 Chimeric Antigen Receptor
CRISPR Therapeutics AG
0 cites - US116791302023Genetically Engineered T Cells with Regnase-1 And/or TGFBRII Disruption Have Improved Functionality and Persistence
CRISPR Therapeutics AG
0 cites - US116791312023Genetically Engineered T Cells with Regnase-1 And/or TGFBRII Disruption Have Improved Functionality and Persistence
CRISPR Therapeutics AG
0 cites